nodes	percent_of_prediction	percent_of_DWPC	metapath
Tafluprost—PTGFR—glaucoma	0.127	0.916	CbGaD
Tafluprost—Prostaglandins—Travoprost—glaucoma	0.0879	0.333	CiPCiCtD
Tafluprost—Prostaglandins—Bimatoprost—glaucoma	0.0879	0.333	CiPCiCtD
Tafluprost—Prostaglandins—Latanoprost—glaucoma	0.0879	0.333	CiPCiCtD
Tafluprost—Travoprost—glaucoma	0.0838	0.362	CrCtD
Tafluprost—Latanoprost—glaucoma	0.0779	0.337	CrCtD
Tafluprost—PTGFR—Travoprost—glaucoma	0.0696	0.451	CbGbCtD
Tafluprost—Bimatoprost—glaucoma	0.0695	0.3	CrCtD
Tafluprost—PTGFR—Latanoprost—glaucoma	0.0449	0.29	CbGbCtD
Tafluprost—PTGFR—Bimatoprost—glaucoma	0.04	0.259	CbGbCtD
Tafluprost—Iloprost—Latanoprost—glaucoma	0.0193	0.127	CrCrCtD
Tafluprost—Iloprost—Bimatoprost—glaucoma	0.0172	0.113	CrCrCtD
Tafluprost—Carboprost Tromethamine—Travoprost—glaucoma	0.0138	0.0906	CrCrCtD
Tafluprost—Travoprost—Latanoprost—glaucoma	0.0128	0.0843	CrCrCtD
Tafluprost—Latanoprost—Travoprost—glaucoma	0.0119	0.0783	CrCrCtD
Tafluprost—PTGS2—glaucoma	0.0117	0.0843	CbGaD
Tafluprost—Travoprost—Bimatoprost—glaucoma	0.0114	0.0751	CrCrCtD
Tafluprost—Carboprost Tromethamine—Bimatoprost—glaucoma	0.0114	0.0751	CrCrCtD
Tafluprost—Latanoprost—Bimatoprost—glaucoma	0.00988	0.0649	CrCrCtD
Tafluprost—Bimatoprost—Travoprost—glaucoma	0.00948	0.0622	CrCrCtD
Tafluprost—Dinoprost Tromethamine—Travoprost—glaucoma	0.00948	0.0622	CrCrCtD
Tafluprost—PTGFR—ciliary body—glaucoma	0.00914	0.91	CbGeAlD
Tafluprost—Bimatoprost—Latanoprost—glaucoma	0.00881	0.0579	CrCrCtD
Tafluprost—Dinoprost Tromethamine—Latanoprost—glaucoma	0.00881	0.0579	CrCrCtD
Tafluprost—Dinoprost Tromethamine—Bimatoprost—glaucoma	0.00785	0.0516	CrCrCtD
Tafluprost—PTGFR—Prostaglandin Synthesis and Regulation—ANXA3—glaucoma	0.000526	0.193	CbGpPWpGaD
Tafluprost—PTGFR—eye—glaucoma	0.000497	0.0495	CbGeAlD
Tafluprost—Travoprost—PTGFR—glaucoma	0.000418	0.32	CrCbGaD
Tafluprost—Carboprost Tromethamine—PTGFR—glaucoma	0.000317	0.243	CrCbGaD
Tafluprost—PTGS2—endothelium—glaucoma	0.000278	0.0277	CbGeAlD
Tafluprost—Eye discharge—Dorzolamide—glaucoma	0.000261	0.00578	CcSEcCtD
Tafluprost—Eye discharge—Travoprost—glaucoma	0.00026	0.00575	CcSEcCtD
Tafluprost—Eye discharge—Brinzolamide—glaucoma	0.000256	0.00568	CcSEcCtD
Tafluprost—Punctate keratitis—Brimonidine—glaucoma	0.000255	0.00564	CcSEcCtD
Tafluprost—Latanoprost—PTGFR—glaucoma	0.000251	0.192	CrCbGaD
Tafluprost—Iritis—Latanoprost—glaucoma	0.000247	0.00546	CcSEcCtD
Tafluprost—Common cold—Brimonidine—glaucoma	0.000246	0.00546	CcSEcCtD
Tafluprost—Conjunctival hyperaemia—Carteolol—glaucoma	0.000243	0.00539	CcSEcCtD
Tafluprost—Punctate keratitis—Dorzolamide—glaucoma	0.000243	0.00539	CcSEcCtD
Tafluprost—Punctate keratitis—Travoprost—glaucoma	0.000242	0.00536	CcSEcCtD
Tafluprost—Punctate keratitis—Brinzolamide—glaucoma	0.000239	0.0053	CcSEcCtD
Tafluprost—Conjunctival hyperaemia—Carbachol—glaucoma	0.000233	0.00517	CcSEcCtD
Tafluprost—Erythema of eyelid—Betaxolol—glaucoma	0.000221	0.0049	CcSEcCtD
Tafluprost—Foreign body sensation in eyes—Timolol—glaucoma	0.000213	0.00472	CcSEcCtD
Tafluprost—Conjunctivitis allergic—Timolol—glaucoma	0.000213	0.00472	CcSEcCtD
Tafluprost—Conjunctival hyperaemia—Latanoprost—glaucoma	0.000213	0.00472	CcSEcCtD
Tafluprost—Uveitis—Bimatoprost—glaucoma	0.000208	0.00461	CcSEcCtD
Tafluprost—Bimatoprost—PTGFR—glaucoma	0.000199	0.152	CrCbGaD
Tafluprost—Iritis—Bimatoprost—glaucoma	0.000191	0.00423	CcSEcCtD
Tafluprost—Lacrimation increased—Echothiophate—glaucoma	0.000187	0.00414	CcSEcCtD
Tafluprost—Eyelid oedema—Latanoprost—glaucoma	0.000186	0.00411	CcSEcCtD
Tafluprost—Erythema of eyelid—Timolol—glaucoma	0.000181	0.004	CcSEcCtD
Tafluprost—Uveitis—Travoprost—glaucoma	0.000175	0.00388	CcSEcCtD
Tafluprost—PTGS2—Prostaglandin Synthesis and Regulation—ANXA3—glaucoma	0.000172	0.063	CbGpPWpGaD
Tafluprost—Eye discharge—Betaxolol—glaucoma	0.000171	0.00379	CcSEcCtD
Tafluprost—Iritis—Brimonidine—glaucoma	0.000169	0.00375	CcSEcCtD
Tafluprost—Eye pruritus—Apraclonidine—glaucoma	0.000168	0.00371	CcSEcCtD
Tafluprost—Conjunctival hyperaemia—Bimatoprost—glaucoma	0.000165	0.00366	CcSEcCtD
Tafluprost—Eye pruritus—Bimatoprost—glaucoma	0.000162	0.0036	CcSEcCtD
Tafluprost—Iritis—Travoprost—glaucoma	0.000161	0.00356	CcSEcCtD
Tafluprost—Ocular hyperaemia—Apraclonidine—glaucoma	0.00016	0.00354	CcSEcCtD
Tafluprost—Punctate keratitis—Betaxolol—glaucoma	0.00016	0.00354	CcSEcCtD
Tafluprost—Endophthalmitis—Apraclonidine—glaucoma	0.000157	0.00349	CcSEcCtD
Tafluprost—Eyelid oedema—Apraclonidine—glaucoma	0.000148	0.00329	CcSEcCtD
Tafluprost—Conjunctival hyperaemia—Brimonidine—glaucoma	0.000146	0.00324	CcSEcCtD
Tafluprost—Eyelid oedema—Bimatoprost—glaucoma	0.000144	0.00319	CcSEcCtD
Tafluprost—Eye pruritus—Brimonidine—glaucoma	0.000144	0.00319	CcSEcCtD
Tafluprost—Eye discharge—Timolol—glaucoma	0.00014	0.0031	CcSEcCtD
Tafluprost—Conjunctival hyperaemia—Dorzolamide—glaucoma	0.00014	0.00309	CcSEcCtD
Tafluprost—Conjunctival hyperaemia—Travoprost—glaucoma	0.000139	0.00308	CcSEcCtD
Tafluprost—Eye pruritus—Dorzolamide—glaucoma	0.000137	0.00304	CcSEcCtD
Tafluprost—Conjunctival hyperaemia—Brinzolamide—glaucoma	0.000137	0.00304	CcSEcCtD
Tafluprost—Ocular hyperaemia—Brimonidine—glaucoma	0.000137	0.00304	CcSEcCtD
Tafluprost—Eye pruritus—Travoprost—glaucoma	0.000137	0.00303	CcSEcCtD
Tafluprost—Endophthalmitis—Brimonidine—glaucoma	0.000135	0.00299	CcSEcCtD
Tafluprost—Eye pruritus—Brinzolamide—glaucoma	0.000135	0.00299	CcSEcCtD
Tafluprost—PTGS2—connective tissue—glaucoma	0.000132	0.0131	CbGeAlD
Tafluprost—Ocular hyperaemia—Dorzolamide—glaucoma	0.000131	0.0029	CcSEcCtD
Tafluprost—Punctate keratitis—Timolol—glaucoma	0.000131	0.00289	CcSEcCtD
Tafluprost—Ocular hyperaemia—Travoprost—glaucoma	0.00013	0.00289	CcSEcCtD
Tafluprost—Ocular hyperaemia—Brinzolamide—glaucoma	0.000129	0.00285	CcSEcCtD
Tafluprost—Endophthalmitis—Travoprost—glaucoma	0.000128	0.00285	CcSEcCtD
Tafluprost—Eyelid oedema—Brimonidine—glaucoma	0.000127	0.00282	CcSEcCtD
Tafluprost—Endophthalmitis—Brinzolamide—glaucoma	0.000127	0.00281	CcSEcCtD
Tafluprost—Exacerbation of asthma—Timolol—glaucoma	0.000126	0.0028	CcSEcCtD
Tafluprost—Common cold—Timolol—glaucoma	0.000126	0.0028	CcSEcCtD
Tafluprost—Visual acuity reduced—Apraclonidine—glaucoma	0.000126	0.00279	CcSEcCtD
Tafluprost—Lacrimation increased—Metipranolol—glaucoma	0.000125	0.00278	CcSEcCtD
Tafluprost—Eye irritation—Carteolol—glaucoma	0.000125	0.00277	CcSEcCtD
Tafluprost—Eyelid oedema—Dorzolamide—glaucoma	0.000122	0.0027	CcSEcCtD
Tafluprost—Eyelid oedema—Travoprost—glaucoma	0.000121	0.00268	CcSEcCtD
Tafluprost—Dinoprost Tromethamine—PTGFR—glaucoma	0.000121	0.0924	CrCbGaD
Tafluprost—Eye irritation—Carbachol—glaucoma	0.00012	0.00266	CcSEcCtD
Tafluprost—Eyelid oedema—Brinzolamide—glaucoma	0.00012	0.00265	CcSEcCtD
Tafluprost—PTGFR—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	0.000119	0.0438	CbGpPWpGaD
Tafluprost—PTGS2—Prostaglandin Synthesis and Regulation—PTGFR—glaucoma	0.000117	0.043	CbGpPWpGaD
Tafluprost—Lacrimation increased—Carteolol—glaucoma	0.000116	0.00257	CcSEcCtD
Tafluprost—Eye irritation—Latanoprost—glaucoma	0.00011	0.00243	CcSEcCtD
Tafluprost—Photophobia—Metipranolol—glaucoma	0.000108	0.0024	CcSEcCtD
Tafluprost—Iritis—Betaxolol—glaucoma	0.000106	0.00235	CcSEcCtD
Tafluprost—Visual acuity reduced—Travoprost—glaucoma	0.000103	0.00228	CcSEcCtD
Tafluprost—Lacrimation increased—Latanoprost—glaucoma	0.000102	0.00225	CcSEcCtD
Tafluprost—Visual acuity reduced—Brinzolamide—glaucoma	0.000102	0.00225	CcSEcCtD
Tafluprost—Photophobia—Carteolol—glaucoma	0.0001	0.00222	CcSEcCtD
Tafluprost—Visual acuity reduced—Pilocarpine—glaucoma	9.76e-05	0.00216	CcSEcCtD
Tafluprost—PTGFR—G alpha (q) signalling events—OPN4—glaucoma	9.23e-05	0.0339	CbGpPWpGaD
Tafluprost—Eye pruritus—Betaxolol—glaucoma	9.03e-05	0.002	CcSEcCtD
Tafluprost—Photophobia—Latanoprost—glaucoma	8.8e-05	0.00195	CcSEcCtD
Tafluprost—Eye irritation—Apraclonidine—glaucoma	8.78e-05	0.00194	CcSEcCtD
Tafluprost—Dry eye—Latanoprost—glaucoma	8.66e-05	0.00192	CcSEcCtD
Tafluprost—Ocular hyperaemia—Betaxolol—glaucoma	8.61e-05	0.00191	CcSEcCtD
Tafluprost—Eye irritation—Bimatoprost—glaucoma	8.51e-05	0.00188	CcSEcCtD
Tafluprost—Endophthalmitis—Betaxolol—glaucoma	8.48e-05	0.00188	CcSEcCtD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	8.25e-05	0.0303	CbGpPWpGaD
Tafluprost—Lacrimation increased—Apraclonidine—glaucoma	8.13e-05	0.0018	CcSEcCtD
Tafluprost—Lacrimation increased—Bimatoprost—glaucoma	7.88e-05	0.00175	CcSEcCtD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	7.8e-05	0.0286	CbGpPWpGaD
Tafluprost—Cataract—Bimatoprost—glaucoma	7.63e-05	0.00169	CcSEcCtD
Tafluprost—Eye pain—Latanoprost—glaucoma	7.54e-05	0.00167	CcSEcCtD
Tafluprost—Eye irritation—Brimonidine—glaucoma	7.53e-05	0.00167	CcSEcCtD
Tafluprost—Conjunctival hyperaemia—Timolol—glaucoma	7.5e-05	0.00166	CcSEcCtD
Tafluprost—PTGFR—GPCRs, Other—SMO—glaucoma	7.46e-05	0.0273	CbGpPWpGaD
Tafluprost—Eye pruritus—Timolol—glaucoma	7.37e-05	0.00163	CcSEcCtD
Tafluprost—Eye irritation—Dorzolamide—glaucoma	7.2e-05	0.00159	CcSEcCtD
Tafluprost—Eye irritation—Travoprost—glaucoma	7.16e-05	0.00159	CcSEcCtD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	7.13e-05	0.0262	CbGpPWpGaD
Tafluprost—Vision blurred—Echothiophate—glaucoma	7.09e-05	0.00157	CcSEcCtD
Tafluprost—Eye irritation—Brinzolamide—glaucoma	7.07e-05	0.00157	CcSEcCtD
Tafluprost—Photophobia—Apraclonidine—glaucoma	7.04e-05	0.00156	CcSEcCtD
Tafluprost—Ocular hyperaemia—Timolol—glaucoma	7.03e-05	0.00156	CcSEcCtD
Tafluprost—Lacrimation increased—Brimonidine—glaucoma	6.98e-05	0.00155	CcSEcCtD
Tafluprost—Endophthalmitis—Timolol—glaucoma	6.93e-05	0.00153	CcSEcCtD
Tafluprost—Dry eye—Apraclonidine—glaucoma	6.92e-05	0.00153	CcSEcCtD
Tafluprost—Photophobia—Bimatoprost—glaucoma	6.82e-05	0.00151	CcSEcCtD
Tafluprost—Eye irritation—Pilocarpine—glaucoma	6.8e-05	0.00151	CcSEcCtD
Tafluprost—Visual acuity reduced—Betaxolol—glaucoma	6.79e-05	0.0015	CcSEcCtD
Tafluprost—Cataract—Brimonidine—glaucoma	6.76e-05	0.0015	CcSEcCtD
Tafluprost—Dry eye—Bimatoprost—glaucoma	6.71e-05	0.00149	CcSEcCtD
Tafluprost—Lacrimation increased—Dorzolamide—glaucoma	6.67e-05	0.00148	CcSEcCtD
Tafluprost—PTGFR—Prostaglandin Synthesis and Regulation—PTGS2—glaucoma	6.65e-05	0.0244	CbGpPWpGaD
Tafluprost—Lacrimation increased—Travoprost—glaucoma	6.64e-05	0.00147	CcSEcCtD
Tafluprost—Lacrimation increased—Brinzolamide—glaucoma	6.55e-05	0.00145	CcSEcCtD
Tafluprost—Eyelid oedema—Timolol—glaucoma	6.53e-05	0.00145	CcSEcCtD
Tafluprost—Asthma—Carbachol—glaucoma	6.44e-05	0.00143	CcSEcCtD
Tafluprost—Cataract—Travoprost—glaucoma	6.43e-05	0.00142	CcSEcCtD
Tafluprost—Lacrimation increased—Pilocarpine—glaucoma	6.3e-05	0.0014	CcSEcCtD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	6.11e-05	0.0224	CbGpPWpGaD
Tafluprost—Cataract—Pilocarpine—glaucoma	6.1e-05	0.00135	CcSEcCtD
Tafluprost—Photophobia—Brimonidine—glaucoma	6.04e-05	0.00134	CcSEcCtD
Tafluprost—Eye pain—Apraclonidine—glaucoma	6.03e-05	0.00133	CcSEcCtD
Tafluprost—Dry eye—Brimonidine—glaucoma	5.94e-05	0.00132	CcSEcCtD
Tafluprost—Asthma—Latanoprost—glaucoma	5.88e-05	0.0013	CcSEcCtD
Tafluprost—Eye pain—Bimatoprost—glaucoma	5.84e-05	0.00129	CcSEcCtD
Tafluprost—Rhinitis—Metipranolol—glaucoma	5.81e-05	0.00129	CcSEcCtD
Tafluprost—Photophobia—Dorzolamide—glaucoma	5.77e-05	0.00128	CcSEcCtD
Tafluprost—Photophobia—Travoprost—glaucoma	5.74e-05	0.00127	CcSEcCtD
Tafluprost—Dry eye—Dorzolamide—glaucoma	5.67e-05	0.00126	CcSEcCtD
Tafluprost—Photophobia—Brinzolamide—glaucoma	5.67e-05	0.00126	CcSEcCtD
Tafluprost—Dry eye—Travoprost—glaucoma	5.65e-05	0.00125	CcSEcCtD
Tafluprost—Dry eye—Brinzolamide—glaucoma	5.58e-05	0.00124	CcSEcCtD
Tafluprost—Visual acuity reduced—Timolol—glaucoma	5.54e-05	0.00123	CcSEcCtD
Tafluprost—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—glaucoma	5.42e-05	0.0199	CbGpPWpGaD
Tafluprost—Dry eye—Pilocarpine—glaucoma	5.36e-05	0.00119	CcSEcCtD
Tafluprost—PTGS2—C-MYB transcription factor network—CA1—glaucoma	5.31e-05	0.0195	CbGpPWpGaD
Tafluprost—Eye pain—Brimonidine—glaucoma	5.17e-05	0.00115	CcSEcCtD
Tafluprost—Urinary tract infection—Latanoprost—glaucoma	5.1e-05	0.00113	CcSEcCtD
Tafluprost—Eye pain—Dorzolamide—glaucoma	4.94e-05	0.00109	CcSEcCtD
Tafluprost—Eye pain—Travoprost—glaucoma	4.92e-05	0.00109	CcSEcCtD
Tafluprost—Nasopharyngitis—Apraclonidine—glaucoma	4.86e-05	0.00108	CcSEcCtD
Tafluprost—Eye pain—Brinzolamide—glaucoma	4.86e-05	0.00108	CcSEcCtD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	4.79e-05	0.0176	CbGpPWpGaD
Tafluprost—Vision blurred—Metipranolol—glaucoma	4.76e-05	0.00105	CcSEcCtD
Tafluprost—Eye irritation—Betaxolol—glaucoma	4.73e-05	0.00105	CcSEcCtD
Tafluprost—Nasopharyngitis—Bimatoprost—glaucoma	4.72e-05	0.00104	CcSEcCtD
Tafluprost—Asthma—Apraclonidine—glaucoma	4.7e-05	0.00104	CcSEcCtD
Tafluprost—Eye pain—Pilocarpine—glaucoma	4.67e-05	0.00103	CcSEcCtD
Tafluprost—PTGFR—GPCR ligand binding—OPN4—glaucoma	4.65e-05	0.0171	CbGpPWpGaD
Tafluprost—Asthma—Bimatoprost—glaucoma	4.56e-05	0.00101	CcSEcCtD
Tafluprost—Vision blurred—Carteolol—glaucoma	4.41e-05	0.000976	CcSEcCtD
Tafluprost—Cough—Metipranolol—glaucoma	4.4e-05	0.000976	CcSEcCtD
Tafluprost—Lacrimation increased—Betaxolol—glaucoma	4.38e-05	0.00097	CcSEcCtD
Tafluprost—PTGS2—Overview of nanoparticle effects—FN1—glaucoma	4.31e-05	0.0158	CbGpPWpGaD
Tafluprost—Dry eye—Clonidine—glaucoma	4.28e-05	0.000948	CcSEcCtD
Tafluprost—Cataract—Betaxolol—glaucoma	4.24e-05	0.000939	CcSEcCtD
Tafluprost—Nasopharyngitis—Brimonidine—glaucoma	4.18e-05	0.000925	CcSEcCtD
Tafluprost—Nasopharyngitis—Brinzolamide—glaucoma	3.92e-05	0.000868	CcSEcCtD
Tafluprost—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	3.9e-05	0.0143	CbGpPWpGaD
Tafluprost—Vision blurred—Latanoprost—glaucoma	3.86e-05	0.000855	CcSEcCtD
Tafluprost—Eye irritation—Timolol—glaucoma	3.86e-05	0.000855	CcSEcCtD
Tafluprost—Asthma—Travoprost—glaucoma	3.84e-05	0.00085	CcSEcCtD
Tafluprost—Photophobia—Betaxolol—glaucoma	3.79e-05	0.000839	CcSEcCtD
Tafluprost—Asthma—Brinzolamide—glaucoma	3.79e-05	0.000839	CcSEcCtD
Tafluprost—Rhinitis—Apraclonidine—glaucoma	3.77e-05	0.000836	CcSEcCtD
Tafluprost—Dry eye—Betaxolol—glaucoma	3.73e-05	0.000826	CcSEcCtD
Tafluprost—Dyspnoea—Metipranolol—glaucoma	3.67e-05	0.000814	CcSEcCtD
Tafluprost—Rhinitis—Bimatoprost—glaucoma	3.66e-05	0.00081	CcSEcCtD
Tafluprost—Lacrimation increased—Timolol—glaucoma	3.58e-05	0.000793	CcSEcCtD
Tafluprost—Eye disorder—Apraclonidine—glaucoma	3.52e-05	0.000779	CcSEcCtD
Tafluprost—Cataract—Timolol—glaucoma	3.46e-05	0.000767	CcSEcCtD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	3.42e-05	0.0126	CbGpPWpGaD
Tafluprost—Eye disorder—Bimatoprost—glaucoma	3.41e-05	0.000755	CcSEcCtD
Tafluprost—Dyspnoea—Carteolol—glaucoma	3.4e-05	0.000754	CcSEcCtD
Tafluprost—Urinary tract infection—Dorzolamide—glaucoma	3.34e-05	0.00074	CcSEcCtD
Tafluprost—Urinary tract infection—Travoprost—glaucoma	3.33e-05	0.000737	CcSEcCtD
Tafluprost—PTGS2—Selenium Micronutrient Network—TXN—glaucoma	3.3e-05	0.0121	CbGpPWpGaD
Tafluprost—Nervous system disorder—Latanoprost—glaucoma	3.28e-05	0.000726	CcSEcCtD
Tafluprost—Eye pain—Betaxolol—glaucoma	3.25e-05	0.000719	CcSEcCtD
Tafluprost—Rhinitis—Brimonidine—glaucoma	3.24e-05	0.000717	CcSEcCtD
Tafluprost—Dyspnoea—Levobunolol—glaucoma	3.22e-05	0.000712	CcSEcCtD
Tafluprost—PTGS2—Arachidonic acid metabolism—CYP1B1—glaucoma	3.2e-05	0.0117	CbGpPWpGaD
Tafluprost—Urinary tract infection—Pilocarpine—glaucoma	3.16e-05	0.000699	CcSEcCtD
Tafluprost—Photophobia—Timolol—glaucoma	3.1e-05	0.000686	CcSEcCtD
Tafluprost—Vision blurred—Apraclonidine—glaucoma	3.09e-05	0.000684	CcSEcCtD
Tafluprost—Rhinitis—Travoprost—glaucoma	3.08e-05	0.000682	CcSEcCtD
Tafluprost—Dry eye—Timolol—glaucoma	3.05e-05	0.000675	CcSEcCtD
Tafluprost—Rhinitis—Brinzolamide—glaucoma	3.04e-05	0.000674	CcSEcCtD
Tafluprost—Eye disorder—Brimonidine—glaucoma	3.02e-05	0.000669	CcSEcCtD
Tafluprost—Nasopharyngitis—Clonidine—glaucoma	3.01e-05	0.000667	CcSEcCtD
Tafluprost—Vision blurred—Bimatoprost—glaucoma	2.99e-05	0.000663	CcSEcCtD
Tafluprost—Dyspnoea—Latanoprost—glaucoma	2.98e-05	0.00066	CcSEcCtD
Tafluprost—PTGS2—Spinal Cord Injury—C1QB—glaucoma	2.93e-05	0.0107	CbGpPWpGaD
Tafluprost—Rhinitis—Pilocarpine—glaucoma	2.92e-05	0.000647	CcSEcCtD
Tafluprost—Asthma—Clonidine—glaucoma	2.91e-05	0.000644	CcSEcCtD
Tafluprost—Eye disorder—Travoprost—glaucoma	2.87e-05	0.000636	CcSEcCtD
Tafluprost—Eye disorder—Brinzolamide—glaucoma	2.83e-05	0.000628	CcSEcCtD
Tafluprost—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—glaucoma	2.83e-05	0.0104	CbGpPWpGaD
Tafluprost—Cough—Bimatoprost—glaucoma	2.77e-05	0.000614	CcSEcCtD
Tafluprost—PTGFR—G alpha (q) signalling events—EDN1—glaucoma	2.76e-05	0.0101	CbGpPWpGaD
Tafluprost—Eye disorder—Pilocarpine—glaucoma	2.72e-05	0.000603	CcSEcCtD
Tafluprost—Pruritus—Diclofenamide—glaucoma	2.65e-05	0.000588	CcSEcCtD
Tafluprost—Eye pain—Timolol—glaucoma	2.65e-05	0.000587	CcSEcCtD
Tafluprost—Vision blurred—Brimonidine—glaucoma	2.65e-05	0.000587	CcSEcCtD
Tafluprost—PTGFR—GPCR downstream signaling—OPN4—glaucoma	2.63e-05	0.00965	CbGpPWpGaD
Tafluprost—Nervous system disorder—Apraclonidine—glaucoma	2.62e-05	0.000581	CcSEcCtD
Tafluprost—Nasopharyngitis—Betaxolol—glaucoma	2.62e-05	0.00058	CcSEcCtD
Tafluprost—Headache—Metipranolol—glaucoma	2.58e-05	0.000572	CcSEcCtD
Tafluprost—Pruritus—Levobunolol—glaucoma	2.55e-05	0.000565	CcSEcCtD
Tafluprost—Nervous system disorder—Bimatoprost—glaucoma	2.54e-05	0.000563	CcSEcCtD
Tafluprost—Asthma—Betaxolol—glaucoma	2.53e-05	0.000561	CcSEcCtD
Tafluprost—Vision blurred—Dorzolamide—glaucoma	2.53e-05	0.000561	CcSEcCtD
Tafluprost—Urinary tract infection—Clonidine—glaucoma	2.52e-05	0.000558	CcSEcCtD
Tafluprost—Vision blurred—Travoprost—glaucoma	2.52e-05	0.000558	CcSEcCtD
Tafluprost—Vision blurred—Brinzolamide—glaucoma	2.49e-05	0.000551	CcSEcCtD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	2.47e-05	0.00906	CbGpPWpGaD
Tafluprost—PTGS2—S1P1 pathway—VEGFA—glaucoma	2.47e-05	0.00904	CbGpPWpGaD
Tafluprost—Cough—Brimonidine—glaucoma	2.45e-05	0.000544	CcSEcCtD
Tafluprost—Vision blurred—Pilocarpine—glaucoma	2.39e-05	0.00053	CcSEcCtD
Tafluprost—Headache—Carteolol—glaucoma	2.39e-05	0.00053	CcSEcCtD
Tafluprost—PTGFR—Signaling by GPCR—OPN4—glaucoma	2.39e-05	0.00876	CbGpPWpGaD
Tafluprost—Dyspnoea—Apraclonidine—glaucoma	2.38e-05	0.000528	CcSEcCtD
Tafluprost—Pruritus—Latanoprost—glaucoma	2.37e-05	0.000524	CcSEcCtD
Tafluprost—Headache—Diclofenamide—glaucoma	2.35e-05	0.000521	CcSEcCtD
Tafluprost—Cough—Dorzolamide—glaucoma	2.34e-05	0.000519	CcSEcCtD
Tafluprost—Rhinitis—Clonidine—glaucoma	2.33e-05	0.000517	CcSEcCtD
Tafluprost—Cough—Travoprost—glaucoma	2.33e-05	0.000517	CcSEcCtD
Tafluprost—Dyspnoea—Bimatoprost—glaucoma	2.31e-05	0.000512	CcSEcCtD
Tafluprost—Cough—Brinzolamide—glaucoma	2.3e-05	0.00051	CcSEcCtD
Tafluprost—Headache—Carbachol—glaucoma	2.29e-05	0.000508	CcSEcCtD
Tafluprost—Headache—Levobunolol—glaucoma	2.26e-05	0.0005	CcSEcCtD
Tafluprost—Nervous system disorder—Brimonidine—glaucoma	2.25e-05	0.000499	CcSEcCtD
Tafluprost—Cough—Pilocarpine—glaucoma	2.21e-05	0.000491	CcSEcCtD
Tafluprost—Eye disorder—Clonidine—glaucoma	2.18e-05	0.000482	CcSEcCtD
Tafluprost—Headache—Methazolamide—glaucoma	2.16e-05	0.000479	CcSEcCtD
Tafluprost—Nervous system disorder—Travoprost—glaucoma	2.14e-05	0.000474	CcSEcCtD
Tafluprost—Nasopharyngitis—Timolol—glaucoma	2.14e-05	0.000474	CcSEcCtD
Tafluprost—Nervous system disorder—Brinzolamide—glaucoma	2.11e-05	0.000468	CcSEcCtD
Tafluprost—PTGFR—GPCR ligand binding—SMO—glaucoma	2.11e-05	0.00775	CbGpPWpGaD
Tafluprost—PTGS2—Overview of nanoparticle effects—TNF—glaucoma	2.11e-05	0.00775	CbGpPWpGaD
Tafluprost—Headache—Latanoprost—glaucoma	2.1e-05	0.000464	CcSEcCtD
Tafluprost—Asthma—Timolol—glaucoma	2.07e-05	0.000458	CcSEcCtD
Tafluprost—Dyspnoea—Brimonidine—glaucoma	2.05e-05	0.000453	CcSEcCtD
Tafluprost—PTGS2—Selenium Micronutrient Network—ABCA1—glaucoma	2.04e-05	0.00747	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—LRP12—glaucoma	2.04e-05	0.00747	CbGpPWpGaD
Tafluprost—Rhinitis—Betaxolol—glaucoma	2.03e-05	0.00045	CcSEcCtD
Tafluprost—Dyspnoea—Dorzolamide—glaucoma	1.95e-05	0.000433	CcSEcCtD
Tafluprost—Dyspnoea—Travoprost—glaucoma	1.95e-05	0.000431	CcSEcCtD
Tafluprost—Dyspnoea—Brinzolamide—glaucoma	1.92e-05	0.000426	CcSEcCtD
Tafluprost—Vision blurred—Clonidine—glaucoma	1.91e-05	0.000423	CcSEcCtD
Tafluprost—Eye disorder—Betaxolol—glaucoma	1.89e-05	0.00042	CcSEcCtD
Tafluprost—Pruritus—Apraclonidine—glaucoma	1.89e-05	0.000419	CcSEcCtD
Tafluprost—Dyspnoea—Pilocarpine—glaucoma	1.85e-05	0.000409	CcSEcCtD
Tafluprost—Pruritus—Bimatoprost—glaucoma	1.83e-05	0.000406	CcSEcCtD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	1.83e-05	0.00671	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—SOD1—glaucoma	1.82e-05	0.00666	CbGpPWpGaD
Tafluprost—Cough—Clonidine—glaucoma	1.77e-05	0.000392	CcSEcCtD
Tafluprost—PTGS2—C-MYB transcription factor network—GSTM1—glaucoma	1.69e-05	0.0062	CbGpPWpGaD
Tafluprost—Headache—Apraclonidine—glaucoma	1.67e-05	0.000371	CcSEcCtD
Tafluprost—Vision blurred—Betaxolol—glaucoma	1.66e-05	0.000368	CcSEcCtD
Tafluprost—Rhinitis—Timolol—glaucoma	1.66e-05	0.000368	CcSEcCtD
Tafluprost—Pruritus—Brimonidine—glaucoma	1.62e-05	0.00036	CcSEcCtD
Tafluprost—Headache—Bimatoprost—glaucoma	1.62e-05	0.00036	CcSEcCtD
Tafluprost—Nervous system disorder—Clonidine—glaucoma	1.62e-05	0.000359	CcSEcCtD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.6e-05	0.00586	CbGpPWpGaD
Tafluprost—Pruritus—Dorzolamide—glaucoma	1.55e-05	0.000344	CcSEcCtD
Tafluprost—PTGS2—Spinal Cord Injury—NGFR—glaucoma	1.55e-05	0.00569	CbGpPWpGaD
Tafluprost—Eye disorder—Timolol—glaucoma	1.55e-05	0.000343	CcSEcCtD
Tafluprost—Pruritus—Travoprost—glaucoma	1.54e-05	0.000342	CcSEcCtD
Tafluprost—Cough—Betaxolol—glaucoma	1.54e-05	0.000341	CcSEcCtD
Tafluprost—Pruritus—Brinzolamide—glaucoma	1.52e-05	0.000338	CcSEcCtD
Tafluprost—Headache—Acetazolamide—glaucoma	1.5e-05	0.000332	CcSEcCtD
Tafluprost—Dyspnoea—Clonidine—glaucoma	1.47e-05	0.000327	CcSEcCtD
Tafluprost—Pruritus—Pilocarpine—glaucoma	1.47e-05	0.000325	CcSEcCtD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	1.46e-05	0.00536	CbGpPWpGaD
Tafluprost—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—glaucoma	1.45e-05	0.00533	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—MTHFR—glaucoma	1.44e-05	0.00528	CbGpPWpGaD
Tafluprost—Headache—Brimonidine—glaucoma	1.44e-05	0.000318	CcSEcCtD
Tafluprost—Nervous system disorder—Betaxolol—glaucoma	1.41e-05	0.000313	CcSEcCtD
Tafluprost—PTGFR—Signaling Pathways—OPN4—glaucoma	1.41e-05	0.00518	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—EDN1—glaucoma	1.39e-05	0.00511	CbGpPWpGaD
Tafluprost—Headache—Dorzolamide—glaucoma	1.37e-05	0.000304	CcSEcCtD
Tafluprost—Headache—Travoprost—glaucoma	1.37e-05	0.000303	CcSEcCtD
Tafluprost—Vision blurred—Timolol—glaucoma	1.36e-05	0.000301	CcSEcCtD
Tafluprost—Headache—Brinzolamide—glaucoma	1.35e-05	0.000299	CcSEcCtD
Tafluprost—PTGS2—Spinal Cord Injury—BDNF—glaucoma	1.35e-05	0.00495	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	1.34e-05	0.00493	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HEYL—glaucoma	1.31e-05	0.00481	CbGpPWpGaD
Tafluprost—Headache—Pilocarpine—glaucoma	1.3e-05	0.000287	CcSEcCtD
Tafluprost—PTGS2—Spinal Cord Injury—IL1A—glaucoma	1.3e-05	0.00475	CbGpPWpGaD
Tafluprost—Dyspnoea—Betaxolol—glaucoma	1.28e-05	0.000284	CcSEcCtD
Tafluprost—Cough—Timolol—glaucoma	1.26e-05	0.000279	CcSEcCtD
Tafluprost—PTGFR—GPCR ligand binding—C3—glaucoma	1.22e-05	0.00446	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	1.22e-05	0.00446	CbGpPWpGaD
Tafluprost—Pruritus—Clonidine—glaucoma	1.17e-05	0.000259	CcSEcCtD
Tafluprost—Nervous system disorder—Timolol—glaucoma	1.15e-05	0.000256	CcSEcCtD
Tafluprost—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—glaucoma	1.14e-05	0.00419	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	1.11e-05	0.00408	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—SMO—glaucoma	1.08e-05	0.00398	CbGpPWpGaD
Tafluprost—Dyspnoea—Timolol—glaucoma	1.05e-05	0.000232	CcSEcCtD
Tafluprost—PTGS2—Metabolism—CA5A—glaucoma	1.05e-05	0.00385	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—NARFL—glaucoma	1.05e-05	0.00385	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—TNF—glaucoma	1.04e-05	0.00382	CbGpPWpGaD
Tafluprost—Headache—Clonidine—glaucoma	1.04e-05	0.00023	CcSEcCtD
Tafluprost—PTGS2—C-MYB transcription factor network—CDKN2A—glaucoma	1.02e-05	0.00374	CbGpPWpGaD
Tafluprost—Pruritus—Betaxolol—glaucoma	1.02e-05	0.000226	CcSEcCtD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	1e-05	0.00368	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—RPTOR—glaucoma	9.94e-06	0.00365	CbGpPWpGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—glaucoma	9.74e-06	0.00357	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NCK2—glaucoma	9.63e-06	0.00353	CbGpPWpGaD
Tafluprost—PTGS2—Disease—LRP12—glaucoma	9.49e-06	0.00348	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	9.24e-06	0.00339	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	9.18e-06	0.00337	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—CDKN1B—glaucoma	9.03e-06	0.00331	CbGpPWpGaD
Tafluprost—Headache—Betaxolol—glaucoma	9.02e-06	0.0002	CcSEcCtD
Tafluprost—Pruritus—Timolol—glaucoma	8.32e-06	0.000184	CcSEcCtD
Tafluprost—PTGFR—Signaling Pathways—HDAC9—glaucoma	8.19e-06	0.003	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—EDN1—glaucoma	7.87e-06	0.00289	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	7.85e-06	0.00288	CbGpPWpGaD
Tafluprost—Headache—Timolol—glaucoma	7.37e-06	0.000163	CcSEcCtD
Tafluprost—PTGFR—Signaling by GPCR—EDN1—glaucoma	7.15e-06	0.00262	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—C3—glaucoma	6.88e-06	0.00252	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—CDKN1B—glaucoma	6.88e-06	0.00252	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	6.72e-06	0.00246	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SMO—glaucoma	6.41e-06	0.00235	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—MMP9—glaucoma	6.37e-06	0.00234	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—C3—glaucoma	6.25e-06	0.00229	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—TNF—glaucoma	6.2e-06	0.00227	CbGpPWpGaD
Tafluprost—PTGS2—Disease—FGFR1OP—glaucoma	6.11e-06	0.00224	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HEYL—glaucoma	6.11e-06	0.00224	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NTRK2—glaucoma	5.86e-06	0.00215	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CA1—glaucoma	5.12e-06	0.00188	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NGFR—glaucoma	5.03e-06	0.00184	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CTSA—glaucoma	4.96e-06	0.00182	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—TNF—glaucoma	4.9e-06	0.0018	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NTRK1—glaucoma	4.78e-06	0.00175	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CA2—glaucoma	4.68e-06	0.00172	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	4.68e-06	0.00172	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	4.58e-06	0.00168	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	4.58e-06	0.00168	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CDKN2B—glaucoma	4.4e-06	0.00161	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—TP53—glaucoma	4.32e-06	0.00159	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—EDN1—glaucoma	4.22e-06	0.00155	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	3.89e-06	0.00143	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NGF—glaucoma	3.88e-06	0.00142	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HDAC9—glaucoma	3.81e-06	0.0014	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—C3—glaucoma	3.69e-06	0.00135	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—APOE—glaucoma	3.44e-06	0.00126	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CAV1—glaucoma	3.4e-06	0.00125	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	3.33e-06	0.00122	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—TXN—glaucoma	3.3e-06	0.00121	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—FN1—glaucoma	3.24e-06	0.00119	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—BAD—glaucoma	3.2e-06	0.00117	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.01e-06	0.0011	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.98e-06	0.00109	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	2.94e-06	0.00108	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NOS3—glaucoma	2.57e-06	0.000944	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GSTT1—glaucoma	2.56e-06	0.000938	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CDKN1B—glaucoma	2.23e-06	0.000818	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MMP9—glaucoma	2.06e-06	0.000757	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CDKN2B—glaucoma	2.05e-06	0.000752	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ABCA1—glaucoma	2.04e-06	0.000748	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CYP1B1—glaucoma	2.04e-06	0.000748	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—VEGFA—glaucoma	1.85e-06	0.00068	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MTHFR—glaucoma	1.72e-06	0.000631	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GSTM1—glaucoma	1.63e-06	0.000598	CbGpPWpGaD
Tafluprost—PTGS2—Disease—APOE—glaucoma	1.6e-06	0.000587	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CAV1—glaucoma	1.59e-06	0.000582	CbGpPWpGaD
Tafluprost—PTGS2—Disease—BAD—glaucoma	1.49e-06	0.000547	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—MTHFR—glaucoma	1.44e-06	0.000528	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TP53—glaucoma	1.4e-06	0.000514	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—APOE—glaucoma	1.34e-06	0.000492	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CAV1—glaucoma	1.33e-06	0.000487	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NOS3—glaucoma	1.2e-06	0.00044	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CDKN1B—glaucoma	1.04e-06	0.000381	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—NOS3—glaucoma	1e-06	0.000368	CbGpPWpGaD
